- Home
- SNBR vs TIL Comparison
SNBR vs TIL Comparison
Compare SNBR & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNBR
- TIL
- Stock Information
- Founded
- SNBR 1987
- TIL 2018
- Country
- SNBR United States
- TIL United States
- Employees
- SNBR N/A
- TIL N/A
- Industry
- SNBR Home Furnishings
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- SNBR Consumer Discretionary
- TIL Health Care
- Exchange
- SNBR Nasdaq
- TIL Nasdaq
- Market Cap
- SNBR 150.1M
- TIL 177.1M
- IPO Year
- SNBR 1998
- TIL 2021
- Fundamental
- Price
- SNBR $3.73
- TIL $12.78
- Analyst Decision
- SNBR Hold
- TIL Strong Buy
- Analyst Count
- SNBR 3
- TIL 5
- Target Price
- SNBR $8.00
- TIL $100.67
- AVG Volume (30 Days)
- SNBR 873.9K
- TIL 64.3K
- Earning Date
- SNBR 11-05-2025
- TIL 11-13-2025
- Dividend Yield
- SNBR N/A
- TIL N/A
- EPS Growth
- SNBR N/A
- TIL N/A
- EPS
- SNBR N/A
- TIL N/A
- Revenue
- SNBR $1,440,882,000.00
- TIL N/A
- Revenue This Year
- SNBR N/A
- TIL N/A
- Revenue Next Year
- SNBR $1.02
- TIL N/A
- P/E Ratio
- SNBR N/A
- TIL N/A
- Revenue Growth
- SNBR N/A
- TIL N/A
- 52 Week Low
- SNBR $3.58
- TIL $10.80
- 52 Week High
- SNBR $20.73
- TIL $42.79
- Technical
- Relative Strength Index (RSI)
- SNBR 19.51
- TIL 31.39
- Support Level
- SNBR $3.97
- TIL $13.53
- Resistance Level
- SNBR $5.64
- TIL $16.00
- Average True Range (ATR)
- SNBR 0.45
- TIL 1.36
- MACD
- SNBR -0.08
- TIL -0.20
- Stochastic Oscillator
- SNBR 5.74
- TIL 7.60
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.